The Brown School and Washington University School of Medicine in St. Louis have received a $2.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the impact of addressing unmet basic needs among Medicaid beneficiaries with diabetes.
A simple blood test reliably detects signs of brain damage in people on the path to developing Alzheimer’s disease – even before they show signs of confusion and memory loss, according to a new study from the School of Medicine and the German Center for Neurodegenerative Diseases.
By tweaking the recipe for coaxing human stem cells into insulin-secreting beta cells, a team of researchers at the School of Medicine has shown that the resulting cells are more responsive to fluctuating glucose levels in the blood. The finding may lead to a new approach to treating diabetes.
In a new study from the School of Medicine, scientists have blocked the destruction of nerve axons in mice, a step toward helping patients with various neurodegenerative disorders.
Scientists at Washington University in St. Louis plan to use a new imaging technique to get a better look at breast tumors and reduce unnecessary biopsies.
In studying a bacterium that causes disease in hospitalized people, researchers at the School of Medicine have figured out a key step in the transmission of antibiotic resistance from one bacterium to another. Their insight suggests a new strategy for stopping the spread of antibiotic resistance.
A new study from the School of Medicine has found that decreased deep sleep is associated with early signs of Alzheimer’s disease.
The School of Medicine has received a $9 million grant from the National Institutes of Health (NIH) to study the life histories of breast and pancreatic cancers. The grant is part of the NIH’s Human Tumor Atlas Network, a large-scale effort to better understand tumors.
Researchers at the School of Medicine — working with mice with sleep problems similar to those experienced by people with the genetic disease neurofibromatosis type 1 (NF1) — believe the animals will help shed light on insomnia linked to NF1 or other factors.
A new study at the School of Medicine finds disparities between African-Americans and Caucasians in a key biomarker for Alzheimer’s disease — suggesting that tools to diagnose the disease in Caucasian populations may not work as well in African-Americans.